Literature DB >> 10960061

Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat.

T P Robertson1, M Dipp, J P Ward, P I Aaronson, A M Evans.   

Abstract

We have examined the effects of Y-27632, a specific inhibitor of Rho-activated kinases (ROCK I and ROCK II) upon sustained hypoxic pulmonary vasoconstriction (HPV) in both rat isolated small intrapulmonary arteries (IPA) and perfused rat lungs in situ. Y-27632 (100 nM - 3 microM) was found to cause a concentration-dependent inhibition of acute sustained HPV in rat IPA. Application of Y-27632 (10-600 nM) in perfused rat lungs caused no change in basal perfusion pressure, but was found to inhibit HPV in a concentration-dependent manner, resulting in complete ablation of the pressor response to hypoxia at a concentration of 600 nM. Furthermore, addition of Y-27632 at any point during hypoxia caused a reversal of HPV in perfused rat lungs. These results suggest that activation of Rho-associated kinase may be a pivotal step in the generation of sustained HPV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960061      PMCID: PMC1572296          DOI: 10.1038/sj.bjp.0703537

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction.

Authors:  J M Post; J R Hume; S L Archer; E K Weir
Journal:  Am J Physiol       Date:  1992-04

2.  Rho A regulates sustained smooth muscle contraction through cytoskeletal reorganization of HSP27.

Authors:  P Wang; K N Bitar
Journal:  Am J Physiol       Date:  1998-12

3.  Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat.

Authors:  T P Robertson; D Hague; P I Aaronson; J P Ward
Journal:  J Physiol       Date:  2000-06-15       Impact factor: 5.182

Review 4.  The role of the endothelium in hypoxic pulmonary vasoconstriction.

Authors:  J P Ward; T P Robertson
Journal:  Exp Physiol       Date:  1995-09       Impact factor: 2.969

5.  Hypoxic vasoconstriction in rat pulmonary and mesenteric arteries.

Authors:  R M Leach; T P Robertson; C H Twort; J P Ward
Journal:  Am J Physiol       Date:  1994-03

Review 6.  Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action.

Authors:  M W Lee; D L Severson
Journal:  Am J Physiol       Date:  1994-09

7.  Hypoxic vasoconstriction and intracellular Ca2+ in pulmonary arteries: evidence for PKC-independent Ca2+ sensitization.

Authors:  T P Robertson; P I Aaronson; J P Ward
Journal:  Am J Physiol       Date:  1995-01

8.  Acute hypoxia causes membrane depolarization and calcium influx in fetal pulmonary artery smooth muscle cells.

Authors:  D N Cornfield; T Stevens; I F McMurtry; S H Abman; D M Rodman
Journal:  Am J Physiol       Date:  1994-04

9.  A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat.

Authors:  R M Leach; C H Twort; I R Cameron; J P Ward
Journal:  Clin Sci (Lond)       Date:  1992-01       Impact factor: 6.124

10.  Modulation of Ca2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation.

Authors:  A Steusloff; E Paul; L A Semenchuk; J Di Salvo; G Pfitzer
Journal:  Arch Biochem Biophys       Date:  1995-07-10       Impact factor: 4.013

View more
  44 in total

1.  Involvement of Rho-kinase in contraction of guinea-pig aorta induced by prostanoid EP3 receptor agonists.

Authors:  Winnie W C Shum; Geng-Yun Le; Robert L Jones; Alison M Gurney; Yasuharu Sasaki
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 2.  Acute oxygen-sensing mechanisms.

Authors:  E Kenneth Weir; José López-Barneo; Keith J Buckler; Stephen L Archer
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

Review 3.  Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.

Authors:  M Oka; K A Fagan; P L Jones; I F McMurtry
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

4.  Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension.

Authors:  Christophe Guilluy; Vincent Sauzeau; Malvyne Rolli-Derkinderen; Patrice Guérin; Christine Sagan; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

5.  Enhancement of myofilament calcium sensitivity by acute hypoxia in rat distal pulmonary arteries.

Authors:  Letitia Weigand; Larissa A Shimoda; J T Sylvester
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-10       Impact factor: 5.464

Review 6.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

7.  Analysis of responses to the Rho-kinase inhibitor Y-27632 in the pulmonary and systemic vascular bed of the rat.

Authors:  David B Casey; Adeleke M Badejo; Jasdeep S Dhaliwal; James L Sikora; Alex Fokin; Neel H Golwala; Anthony J Greco; Subramanyam N Murthy; Bobby D Nossaman; Albert L Hyman; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-30       Impact factor: 4.733

8.  Sensors and signals: the role of reactive oxygen species in hypoxic pulmonary vasoconstriction.

Authors:  Kimberly A Smith; Paul T Schumacker
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

9.  Effect of chronic perinatal hypoxia on the role of rho-kinase in pulmonary artery contraction in newborn lambs.

Authors:  Arlin B Blood; Michael H Terry; Travis A Merritt; Demosthenes G Papamatheakis; Quintin Blood; Jonathon M Ross; Gordon G Power; Lawrence D Longo; Sean M Wilson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-11-14       Impact factor: 3.619

Review 10.  RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.

Authors:  Scott A Barman; Shu Zhu; Richard E White
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.